Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)
Public ClinicalTrials.gov record NCT02416622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multiple-Site, Phase 1/2, Safety and Efficacy Trial of a Recombinant Adeno-associated Virus Vector Expressing Retinoschisin (rAAV2tYF-CB-hRS1) in Patients With X-linked Retinoschisis
Study identification
- NCT ID
- NCT02416622
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Beacon Therapeutics
- Industry
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- rAAV2tYF-CB-hRS1 Biological
Biological
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Mar 31, 2019
- Completion
- May 8, 2023
- Last update posted
- Jun 11, 2023
2015 – 2023
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Francisco, Dept. of Ophthalmology | San Francisco | California | 94143 | — |
| University of Miami - Miller School of Medicine Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| The Wilmer Eye Institute, Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Massachusetts Eye and Ear Infirmary | Boston | Massachusetts | 02114 | — |
| University of Michigan Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Duke Eye Center, Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Casey Eye Institute, Oregon Health and Sciences University | Portland | Oregon | 97239 | — |
| Retina Foundation of the Southwest | Dallas | Texas | 75231 | — |
| Baylor College of Medicine, Alkek Eye Center | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02416622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 11, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02416622 live on ClinicalTrials.gov.